JP2001500476A5 - - Google Patents

Download PDF

Info

Publication number
JP2001500476A5
JP2001500476A5 JP1998509112A JP50911298A JP2001500476A5 JP 2001500476 A5 JP2001500476 A5 JP 2001500476A5 JP 1998509112 A JP1998509112 A JP 1998509112A JP 50911298 A JP50911298 A JP 50911298A JP 2001500476 A5 JP2001500476 A5 JP 2001500476A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998509112A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001500476A (ja
JP4142743B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/013360 external-priority patent/WO1998004591A1/en
Publication of JP2001500476A publication Critical patent/JP2001500476A/ja
Publication of JP2001500476A5 publication Critical patent/JP2001500476A5/ja
Application granted granted Critical
Publication of JP4142743B2 publication Critical patent/JP4142743B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP50911298A 1996-07-31 1997-07-30 副甲状腺ホルモンに関連する新規ペプチド類似体 Expired - Fee Related JP4142743B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2547196P 1996-07-31 1996-07-31
US60/025,471 1996-07-31
PCT/US1997/013360 WO1998004591A1 (en) 1996-07-31 1997-07-30 Novel parathyroid hormone-related peptide analogs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007302159A Division JP2008074868A (ja) 1996-07-31 2007-11-21 副甲状腺ホルモンに関連する新規ペプチド類似体

Publications (3)

Publication Number Publication Date
JP2001500476A JP2001500476A (ja) 2001-01-16
JP2001500476A5 true JP2001500476A5 (https=) 2005-04-07
JP4142743B2 JP4142743B2 (ja) 2008-09-03

Family

ID=21826255

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50911298A Expired - Fee Related JP4142743B2 (ja) 1996-07-31 1997-07-30 副甲状腺ホルモンに関連する新規ペプチド類似体
JP2007302159A Pending JP2008074868A (ja) 1996-07-31 2007-11-21 副甲状腺ホルモンに関連する新規ペプチド類似体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007302159A Pending JP2008074868A (ja) 1996-07-31 2007-11-21 副甲状腺ホルモンに関連する新規ペプチド類似体

Country Status (8)

Country Link
US (2) US6147186A (https=)
EP (1) EP0917537B1 (https=)
JP (2) JP4142743B2 (https=)
AT (1) ATE304020T1 (https=)
AU (1) AU3819497A (https=)
DE (1) DE69734157T2 (https=)
ES (1) ES2248853T3 (https=)
WO (1) WO1998004591A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69734157T2 (de) * 1996-07-31 2006-07-13 The General Hospital Corp., Boston Parathyroidhormon-verwandthe peptidanaloge
HUP0300891A2 (hu) 1998-05-05 2003-07-28 Beth Israel Deaconess Medical Center, Inc. PTH2 receptor szelektív vegyületek és alkalmazásuk gyógyszerkészítmények előállÍtására
AU1447600A (en) * 1998-10-22 2000-05-08 Thomas J. Gardella Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
AU5877300A (en) * 1999-06-15 2001-01-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Pth2 and pth1 receptor ligands
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
CA2454275C (en) * 2001-07-23 2012-10-23 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
AU2003207512B2 (en) * 2002-01-10 2008-06-12 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
CA2496618A1 (en) * 2002-05-23 2003-12-04 Michael Holick Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
AU2002951372A0 (en) * 2002-09-13 2002-09-26 St Vincent's Institute Of Medical Research Parathyroid hormone-like polypeptides
US7795220B2 (en) * 2003-03-19 2010-09-14 The General Hospital Corporation Conformationally constrained parathyroid hormones with alpha-helix stabilizers
WO2005009358A2 (en) * 2003-07-17 2005-02-03 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
MXPA06013168A (es) * 2004-05-13 2007-05-15 Johnson & Johnson Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.
US20060068426A1 (en) * 2004-08-20 2006-03-30 Tam James P Cyclic peptides and antibodies thereof
WO2007133580A2 (en) * 2006-05-09 2007-11-22 Zelos Therapeutics, Inc. Use of pth (1-31) and optionally g-csf for hematopoietic stimulation
EP2054077A4 (en) * 2006-08-04 2010-10-13 Gen Hospital Corp POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH)
EP1961765A1 (en) * 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
WO2008124166A2 (en) 2007-04-09 2008-10-16 The Board Of Trustees Of The University Of Arkansas Fusion proteins of collagen-binding domain and parathyroid hormone
AU2008282805B2 (en) * 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
EP2411038B1 (en) 2009-03-27 2016-12-28 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
ES2729051T3 (es) 2009-07-29 2019-10-30 Kai Pharmaceuticals Inc Agentes terapéuticos para reducir los niveles de hormona paratiroidea
WO2011143406A2 (en) 2010-05-13 2011-11-17 The General Hospital Corporation Parathyroid hormone analogs and uses thereof
CN104168955A (zh) * 2011-11-10 2014-11-26 凯伊药品公司 拟钙剂及其使用方法
WO2013120060A1 (en) 2012-02-09 2013-08-15 The Board Of Trustees Of The University Of Arkansas Delivery of therapeutic agents by a collagen binding protein
ES2695161T3 (es) 2011-12-14 2019-01-02 Univ Arkansas Administración de agentes terapéuticos mediante una proteína de unión a colágeno
US20160040247A1 (en) 2013-03-15 2016-02-11 Fundació Institut De Recerca Biomèdica (Irb Barcelona) Method for the diagnosis, prognosis, and tratment of cancer metastasis
US11624060B2 (en) 2017-02-10 2023-04-11 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same
WO2019178462A1 (en) 2018-03-16 2019-09-19 The General Hospital Corporation Parathyroid hormone polypeptide conjugates and methods of their use
US12403179B2 (en) 2021-02-18 2025-09-02 The Board Of Trustees Of The University Of Arkansas Release of growth factors at wound healing stages

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341962B1 (en) * 1988-05-09 1995-03-15 Merck & Co. Inc. Humoral hypercalcemic factor antagonists
ATE287898T1 (de) * 1991-04-05 2005-02-15 Gen Hospital Corp Parathyroid-hormon-rezeptor und seine kodierende dna
US5821225A (en) 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
US5977070A (en) 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN
DE69734157T2 (de) * 1996-07-31 2006-07-13 The General Hospital Corp., Boston Parathyroidhormon-verwandthe peptidanaloge

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2000501018A5 (https=)
JP2000500076A5 (https=)
JP2000501324A5 (https=)
JP2000500055A5 (https=)
JP2000510701A5 (https=)
JP2000502472A5 (https=)
JP2000501338A5 (https=)
JP2000500874A5 (https=)
JP2001500720A5 (https=)
JP2000502425A5 (https=)
JP2000502485A5 (https=)
JP2000512956A5 (https=)
JP2000502568A5 (https=)
JP2000511443A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2001507180A5 (https=)
JP2001501936A5 (https=)
JP2000508067A5 (https=)
JP2000501229A5 (https=)
JP2000515405A5 (https=)
JP2000502316A5 (https=)
JP2000500857A5 (https=)
JP2000502714A5 (https=)